Amaç: Difüz parankimal akciğer hastalıkları (DPAH), tanı ve tedavisi çeşitlilik gösteren akciğer parankim tutulumu ile karakterize olan bir grup hastalığı içermektedir. Bu çalışma ile polikliniğimizde bu tanıyı alan hastaların özellikleriyle beraber tanısal ve tedavisel yaklaşımlarımızı sunulması amaçlanmıştır. Gereç ve Yöntemler: Ocak 2005-Aralık 2010 tarihleri arasında polikliniğimize başvuran ve DPAH tanısı alan toplam 145 hasta çalışmaya dâhil edildi. Hastalar tanılarına göre gruplandırılarak değerlendirildi. İzlemde kalan hastaların klinik özellikleri, tedavileri, tedavi yanıtları değerlendirildi. Bulgular: Hastalarımızın %53,7'si kadın, %46,2'si erkek olup, yaş ortalamaları 55,2±13,5 (21-83) yıl idi. Nefes darlığı (%78,6) en sık başvuru yakınmaları idi. Fizik muayenede en sık velkro ral (%68,9) ve çomak parmak (%22,7) bulguları saptandı. Tanılardan idiyopatik interstisyel pnömoniler (%42), sarkoidoz (%24,1) ve kollajen doku hastalığına bağlı akciğer tutulumu (%19,3) çoğunluğu oluşturmaktaydı. Hastaların %60'ında klinik ve radyolojik bulgularla, %40'ında invaziv yöntemler kullanılarak tanı elde edilmiştir. İnvaziv tanı yöntemleriyle tanı elde etme sıklığı sırasıyla; mediastinal veya skalen lenf bezi biyopsisi (%16,5), cerrahi akciğer biyopsisi (%11) ve bronkoskopik tanı yöntemleriyle (%8,2) idi. Tedavi sonuçlarında, iyi seyir gösteren 62 hastanın çoğunluğunu sarkoidoz (%37) ve kollajen doku hastalığı olanlar (%30,6) oluşturuyordu. Sonuç: Bu çalışmadaki DPAH tanılı hastaların dağılımı incelendiğinde, literatürle uyumlu olarak sarkoidoz ve idiyopatik pulmoner fibrozun en sık görüldüğü saptandı. Güncel, daha az invaziv tanı yöntemleri ile ayırıcı tanı uygulanması tedavi başarısını artırma açısından değerlidir.
Anahtar Kelimeler: İdiyopatik intestisyel pnömoniler; sarkoidoz; idiyopatik pulmoner fibröz; kriptojenik organize pnömoni
Objective: Diffuse parenchymal lung diseases (DPLD) includes a group diseases characterised with lung parenchymal damage and have various diagnostic and treatment modalities. By this study, we aimed to present characteristics of our DPAH patients and our diagnostic and therapeutic approaches. Material and Methods: Among patients that have applied to our outpatient clinic between January 2005-December 2010, 145 patients with DPLD diagnosis were evaluated retrospectively. The data regarding their clinical, radiological and laboratory findings were obtained both from their manually filled records and electronic hospital records. Patients were categorized and evaluated according to their final diagnosis. Results: Out of 145 patients 53.7% of them was female and 46.2% of them was male. Mean age of the study population was 55.2±13.5 years (range: 21-83). Dyspnea with 78.6% was the most common symptom at admission and fine crackles (68.9%) and clubbing (22.7%) were the most common physical examination findings. Idiopathic interstitial pneumonia (42%), sarcoidosis (24.1%), lung involvement of connective tissue disease (ILD-CTD) (19.3%) were constituted the most common diagnoses. In the aspect of the mostly used diagnostic procedures, 60% of the patients were diagnosed by using clinical and radiological findings and 40% of the patients were underwent an invassive prochedure. Mediastinal or scalene lymph node biopsy (16.5%), surgical lung biopsy (11%) and bronchoscopic prochedures (8.2%) were the commonly used invassive methods. By considering the treatment results, good clinical and radiological response was found in patients with sarcoidosis (37%) and ILD-CTD (30.6%). Conclusion: In our study, sarcoidosis and idiopathic pulmonary fibrosis were the most commonly seen diseases. Although DPLD is a difficult challenge to diagnose in clinical practice, novel diagnostic approaches are fundamental for appropriate diferantial diagnosis and treatment success.
Keywords: Idiopathic interstitial pneumonia; sarcoidosis; idiopathic pulmonary fibrosis; cryptogenic organizing pneumonia
- Mikolasch TA, Garthwaite HS, Porter JC. Update in diagnosis and management of interstitial lung disease. Clin Med (Lond). 2017;17(2):146-53. [Crossref] [PubMed][PMC]
- Musellim B, Okumus G, Uzaslan E, Akgün M, Cetinkaya E, Turan O, et al. Epidemiology and distribution of interstitial lung diseases in Turkey. Clin Respir J. 2014;8(1):55-62. [Crossref][PubMed]
- Şengül B, Uzun O, Fındık S, Fındık S, Atıcı AG, Erkan L. [The evaluation of 92 interstitial lung disease patients]. Tüberküloz ve Toraks Dergisi. 2009;57(3):314-26.
- Erdoğan Y, Yılmaz Turay Ü. [Idiopathic interstitial pneumonias]. Erdoğan Y, Samurkaşoğlu B, editörler. Difüz Parankimal Akciğer Hastalıkları. 2. Baskı. Ankara: Mesut Matbaacılık San Tic Ltd Şti; 2006. p.1-45. [PubMed]
- Atıkcan S, Ernam D, Atalay F, Ünsal E. [Diffuse interstitial lung disease (A retrospective analysis)]. Turkiye Klinikleri Arch Lung. 2003;4(4):207-12.
- Ertürk A, Gülhan M, Çapan N, Arul M, Kurt B. [Diffuse interstitial lung disease (A retrospective analysis of 58 cases)]. Solunum Hastalıkları. 2000;11(4):367-75.
- Morell F, Reyes L, Doméncech G, De Gracia J, Majó J, Ferrer J. [Diagnoses and diagnostic procedures in 500 consecutive patients with clinical suspicion of interstitial lung disease]. Arch Bronconeumol. 2008;44(4):185-91. [Crossref][PubMed]
- Thomeer MJ, Vansteenkiste J, Verbeken EK, Demedts M. Interstitial lung diseases: characteristics at diagnosis and mortality risk assessment. Respir Med. 2004;98(6):267-73. [Crossref]
- Schmidt SL, Sundaram B, Flaherty KR. Diagnosing fibrotic lung disease: when is high-resolution computed tomography sufficient to make a diagnosis of idiopathic pulmonary fibrosis? Respirology. 2009;14(7):934-9. [Crossref] [PubMed]
- American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165(2):277-304. [Crossref][PubMed]
- Sakamoto K, Yokoyama T, Aso H, Iwaki M, Noma S, Kato K, et al. [Surgical lung biopsy for interstital lung diseases: complications, diagnostic yield and mortality]. Nihon Kokyuki Gakkai Zasshi. 2006;44(10):675-80. [PubMed]
- Gotway MB, Freever MM, Kon TE Jr. Challenges in pulmonary fibrosis. 1: Use of high resolution CT scanning of the lung for the evalution of patients with idiopathic interstitial pneumonias. Thorax. 2007;62(6):546-53. [Crossref][PubMed][PMC]
- Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788-824. [Crossref][PubMed][PMC]
- Reich JM, Brouns MC, O?Connor EA, Edwards MJ. Mediastinoscopy in patients with presumptive stage I sarcoidosis: a risk/benefit, cost/benefit analysis. Chest. 1998;113(1): 147-53. [Crossref][PubMed]
- Morgenthau AS, Iannuzzi MC. Recenta dvances in sarcoidosis. Chest. 2011;139(1): 174-82. [Crossref][PubMed]
- Cetinkaya E, Yildiz P, Kadakal F, Tekin A, Soysal F, Elibol S, et al. Transbronchial needle aspiration in the diagnosis of intrathoracic lymphadenopathy. Respiration. 2002;69(4): 335-8. [Crossref] [PubMed]
- Costabel U, Bonella F, Ohshimo S, Guzman J. Diagnostic modalities in sarcoidosis: BAL, EBUS, and PET. Semin Respir Crit Care Med. 2010;31(4):404-8. [Crossref] [PubMed]
- von Bartheld MB, Dekkers OM, Szlubowski A, Eberhardt R, Herth FJ, in?t Veen JC, et al. Endosonography vs conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANU- LOMA randomized clinical trial. JAMA. 2013;309(23):2457-64. [Crossref][PubMed]
- Davis GS. The role of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS TBNA) in the diagnosis of sarcoidosis. Cancer Cytopathol. 2014;122(4):239-40. [Crossref] [PubMed]
- Zhang D, Liu Y. Surgical lung biopsies in 418 patients with suspected interstitial Lung Disease in China. Intern Med. 2010;49(12):1097- 102. [Crossref][PubMed]
- Ooi A, Iyenger S, Ferguson J, Ritchie AJ. VATS lung biopsy in suspected, diffuse interstitial lung disease provides diagnosis, and alters management strategies. Heart Lung Circ. 2005;14(2):90-2. [Crossref][PubMed]
- Raghu G, Mageto YN, Lockhart D, Schmidt RA, Wood DE, Godwin JD. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study. Chest. 1999;116(5):1168-74. [Crossref][PubMed]
- Collard HR, King TE Jr, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. Changes in clinical and physilogic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003;168(5): 538-42. [Crossref][PubMed]
.: Process List